TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with
- This topic has 0 replies, 1 voice, and was last updated 5 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/31109923
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.